Pernix Therapeutics has applied a unique strategy to the development of our current product line and pipeline of future products. We have marketed our products with an aggressive sales force to build brand loyalty among high-prescribing physicians in key territories in the national market. Over the past several years, we have attained strong prescription volume for our product introductions as well as strong repeat prescription volume due to Pernix representative focus. We have also been successful in increasing our product offerings through development projects and recent acquisitions, and our promotional capabilities from a small regional sales force presence to a large pan-regional / national sales and marketing organization.
We will continue aggressively pursuing targeted business development opportunities through cost-effective acquisitions and specialty niche products, while remaining pediatric focused. Our goal is to become a leading integrated specialty pharmaceutical company that develops and effectively commercializes products in large and growing markets in our focus areas. Our key competitive strengths to help us achieve these goals include the following:
- Platform to Expand into Larger Markets
- Low Cost Infrastructure
- Effective Sales, Marketing and Distribution
- Extensive Specialty Pharmaceutical Management Expertise
At Pernix, we are continually reviewing multiple opportunities through our internal business development and industry consultants. If you would like to contact us regarding business development opportunities, please email us.